Search Within

Gregory J Riely

  1. "Melissa Johnson"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (5)
Groups
  1. Department of Medicine (11)
  2. Solid Tumor Oncology Division (11)
  3. Thoracic Oncology (11)
  4. Department of Pathology and Laboratory Medicine (6)
  5. GSK Faculty (6)
  6. Human Oncology and Pathogenesis Program (6)

More Groups

People
  1. Mark Kris (11)
  2. Melissa Johnson (11)
  3. Camelia Sima (6)
  4. Marc Ladanyi (6)
  5. Vincent Miller (6)
  6. Maureen Zakowski (4)

More People

Years
  1. 2013 (1)
  2. 2012 (1)
  3. 2011 (4)
  4. 2010 (3)
  5. 2009 (2)
Publications
  1. Journal of Clinical Oncology (5)
  2. Journal of Thoracic Oncology (5)
  3. Clinical Cancer Research (1)
Publishers
  1. American Society of Clinical Oncology (5)
  2. Elsevier Inc. (5)
  3. American Association for Cancer Research (1)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lungs don't forget: Comparison of the KRAS and EGFR mutation profile and survival of collegiate smokers and never smokers with advanced lung cancers
    Journal Article

    Varghese, A. M.; Sima, C. S.; Chaft, J. E.; Johnson, M. L.; Riely, G. J.; Ladanyi, M.; Kris, M. G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: Higher susceptibility of women to smoking-related KRAS-mutant cancers
    Journal Article

    Dogan, S.; Shen, R.; Ang, D. C.; Johnson, M. L.; D'Angelo, S. P.; Paik, P. K.; Brzostowski, E. B.; Riely, G. J.; Kris, M. G.; Zakowski, M. F.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • A phase II trial of salirasib in patients with lung adenocarcinomas with KRAS mutations
    Journal Article

    Riely, G. J.; Johnson, M. L.; Medina, C.; Rizvi, N. A.; Miller, V. A.; Kris, M. G.; Pietanza, M. C.; Azzoli, C. G.; Krug, L. M.; Pao, W.; more...
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Phase II trial of dasatinib for patients with acquired resistance to treatment with the epidermal growth factor receptor tyrosine kinase inhibitors erlotinib or gefitinib
    Journal Article

    Johnson, M. L.; Riely, G. J.; Rizvi, N. A.; Azzoli, C. G.; Kris, M. G.; Sima, C. S.; Ginsberg, M. S.; Pao, W.; Miller, V. A.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Incidence of EGFR Exon 19 deletions and L858R in tumor specimens from men and cigarette smokers with lung adenocarcinomas
    Journal Article

    D'Angelo, S. P.; Pietanza, M. C.; Johnson, M. L.; Riely, G. J.; Miller, V. A.; Sima, C. S.; Zakowski, M. F.; Rusch, V. W.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Frequency of EGFR and KRAS mutations in lung adenocarcinomas in african americans
    Journal Article

    Reinersman, J. M.; Johnson, M. L.; Riely, G. J.; Chitale, D. A.; Nicastri, A. D.; Soff, G. A.; Schwartz, A. G.; Sima, C. S.; Ayalew, G.; Lau, C.; more...
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Prognostic implications of mutations in the epidermal growth factor receptor (EGFR) and KRAS among never-smokers with adenocarcinoma of the lung
    Meeting Abstract

    Paik, P. K.; Johnson, M. L.; D'Angelo, S. P.; Sima, C.; Janjigian, Y. Y.; Riely, G. J.; Kris, M. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • EGFR mutations in men and cigarette smokers with lung adenocarcinoma
    Meeting Abstract

    Pietanza, M.; D'Angelo, S. P.; Johnson, M. L.; Paik, P. K.; Riely, G. J.; Miller, V. A.; Zakowski, M. F.; Rusch, V. W.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinoma
    Meeting Abstract

    Johnson, M. L.; Sima, C.; Paik, P. K.; Janjigian, Y. Y.; Pao, W.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase II trial of salirasib in patients with stage IIIB/IV lung adenocarcinoma enriched for KRAS mutations
    Meeting Abstract

    Johnson, M. L.; Rizvi, N. A.; Ginsberg, M. S.; Miller, V. A.; Kris, M. G.; Pao, W.; Riely, G. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save